152 related articles for article (PubMed ID: 36931980)
21. Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
Irazabal MV; Abebe KZ; Bae KT; Perrone RD; Chapman AB; Schrier RW; Yu AS; Braun WE; Steinman TI; Harris PC; Flessner MF; Torres VE;
Nephrol Dial Transplant; 2017 Nov; 32(11):1857-1865. PubMed ID: 27484667
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Chest Radiograph Interpretations by Artificial Intelligence Algorithm vs Radiology Residents.
Wu JT; Wong KCL; Gur Y; Ansari N; Karargyris A; Sharma A; Morris M; Saboury B; Ahmad H; Boyko O; Syed A; Jadhav A; Wang H; Pillai A; Kashyap S; Moradi M; Syeda-Mahmood T
JAMA Netw Open; 2020 Oct; 3(10):e2022779. PubMed ID: 33034642
[TBL] [Abstract][Full Text] [Related]
23. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose.
Bevilacqua MU; Hague CJ; Romann A; Sheitt H; Vasilescu DM; Yi TW; Levin A
Radiology; 2019 Jun; 291(3):660-667. PubMed ID: 30964424
[TBL] [Abstract][Full Text] [Related]
24. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
Chebib FT; Torres VE
Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
[TBL] [Abstract][Full Text] [Related]
25. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
[TBL] [Abstract][Full Text] [Related]
26. Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys.
Kline TL; Korfiatis P; Edwards ME; Blais JD; Czerwiec FS; Harris PC; King BF; Torres VE; Erickson BJ
J Digit Imaging; 2017 Aug; 30(4):442-448. PubMed ID: 28550374
[TBL] [Abstract][Full Text] [Related]
27. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
28. Implementation and prospective clinical validation of AI-based planning and shimming techniques in cardiac MRI.
Edalati M; Zheng Y; Watkins MP; Chen J; Liu L; Zhang S; Song Y; Soleymani S; Lenihan DJ; Lanza GM
Med Phys; 2022 Jan; 49(1):129-143. PubMed ID: 34748660
[TBL] [Abstract][Full Text] [Related]
29. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
Sharma K; Caroli A; Quach LV; Petzold K; Bozzetto M; Serra AL; Remuzzi G; Remuzzi A
PLoS One; 2017; 12(5):e0178488. PubMed ID: 28558028
[TBL] [Abstract][Full Text] [Related]
30. Volume regression of native polycystic kidneys after renal transplantation.
Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
[TBL] [Abstract][Full Text] [Related]
31. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
32. Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD.
Demoulin N; Nicola V; Michoux N; Gillion V; Ho TA; Clerckx C; Pirson Y; Annet L
Kidney Int Rep; 2021 Nov; 6(11):2821-2829. PubMed ID: 34805634
[TBL] [Abstract][Full Text] [Related]
33. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
34. Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.
Turco D; Severi S; Mignani R; Aiello V; Magistroni R; Corsi C
Acad Radiol; 2015 Nov; 22(11):1376-84. PubMed ID: 26276168
[TBL] [Abstract][Full Text] [Related]
35. Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
Spithoven EM; van Gastel MD; Messchendorp AL; Casteleijn NF; Drenth JP; Gaillard CA; de Fijter JW; Meijer E; Peters DJ; Kappert P; Renken RJ; Visser FW; Wetzels JF; Zietse R; Gansevoort RT; ;
Am J Kidney Dis; 2015 Nov; 66(5):792-801. PubMed ID: 26235803
[TBL] [Abstract][Full Text] [Related]
36. Development and Evaluation of a Semi-automated Segmentation Tool and a Modified Ellipsoid Formula for Volumetric Analysis of the Kidney in Non-contrast T2-Weighted MR Images.
Seuss H; Janka R; Prümmer M; Cavallaro A; Hammon R; Theis R; Sandmair M; Amann K; Bäuerle T; Uder M; Hammon M
J Digit Imaging; 2017 Apr; 30(2):244-254. PubMed ID: 28025731
[TBL] [Abstract][Full Text] [Related]
37. Intraobserver and interobserver variability of renal volume measurements in polycystic kidney disease using a semiautomated MR segmentation algorithm.
Cohen BA; Barash I; Kim DC; Sanger MD; Babb JS; Chandarana H
AJR Am J Roentgenol; 2012 Aug; 199(2):387-93. PubMed ID: 22826401
[TBL] [Abstract][Full Text] [Related]
38. Abdominal Imaging in ADPKD: Beyond Total Kidney Volume.
Caroli A; Kline TL
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568535
[TBL] [Abstract][Full Text] [Related]
39. Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease.
Iijima H; Tada T; Hashimoto M; Nishimura T; Kiriki M; Higashiura A; Iwasaki A; Honda M; Nagasawa Y; Yamakado K
J Med Ultrason (2001); 2023 Jan; 50(1):81-87. PubMed ID: 36333536
[TBL] [Abstract][Full Text] [Related]
40. Comparison of manual and artificial intelligence based quantification of myocardial strain by feature tracking-a cardiovascular MR study in health and disease.
Gröschel J; Kuhnt J; Viezzer D; Hadler T; Hormes S; Barckow P; Schulz-Menger J; Blaszczyk E
Eur Radiol; 2024 Feb; 34(2):1003-1015. PubMed ID: 37594523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
